Japan starts clinical trials of vaccine against coronavirus

Source : 112 Ukraine

The sale of the vaccine is planned for the next autumn
17:22, 30 June 2020

Open source

Anges.Inc, the Japanese developer of DNA-vaccine against coronavirus, proceeded to the clinical trials on two groups consisting of 30 volunteers, as kyodonews reported.

The first part of the clinical trials consists of the vaccination of 30 healthy volunteers. It is planned to open the sale of the vaccines in autumn 2021 if it is safe and efficient.

The trials will last eight days. One group of 15 people will get more vaccines than the other one. Each person will get two intramuscular injections.

Related: Russia ready to supply vaccine against coronavirus to world markets

The registered person will be observed until July 2021.

As we reported, Israel will receive the first vaccines against coronavirus in December; the respective contract is already signed. We are talking about vaccines, the development of which is at the final stage of clinical trials. The first stage to verify the safety of the drug was completed successfully, and the second stage was completed recently.


Система Orphus

If you find an error, highlight the desired text and press Ctrl + Enter, to tell about it

see more